Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma. [electronic resource]
Producer: 20200929Description: 609-613 p. digitalISSN:- 1600-0625
- Administration, Topical
- Animals
- Carcinoma, Squamous Cell -- drug therapy
- Dasatinib -- administration & dosage
- Fluorouracil -- administration & dosage
- Humans
- Imidazoles -- administration & dosage
- Inflammation
- Keratinocytes -- pathology
- Keratosis, Actinic -- drug therapy
- Mice
- Mice, Transgenic
- Protein Kinase Inhibitors -- administration & dosage
- Quinolines -- administration & dosage
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.